218 related articles for article (PubMed ID: 15721297)
1. Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.
Pantouli E; Boehm MM; Koka S
Biochem Biophys Res Commun; 2005 Apr; 329(1):224-9. PubMed ID: 15721297
[TBL] [Abstract][Full Text] [Related]
2. Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.
Kusumi A; Sakaki H; Kusumi T; Oda M; Narita K; Nakagawa H; Kubota K; Satoh H; Kimura H
J Bone Miner Metab; 2005; 23(5):373-81. PubMed ID: 16133687
[TBL] [Abstract][Full Text] [Related]
3. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1beta-induced chemokine secretion via MAP kinase signaling pathways.
Fyfe M; Bergström M; Aspengren S; Peterson A
Cytokine; 2005 Sep; 31(5):358-67. PubMed ID: 16095910
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
6. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
7. Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells.
Lambert C; Oury C; Dejardin E; Chariot A; Piette J; Malaise M; Merville MP; Franchimont N
J Bone Miner Res; 2007 Sep; 22(9):1350-61. PubMed ID: 17501665
[TBL] [Abstract][Full Text] [Related]
8. Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.
Nakao T; Kim S; Ohta K; Kawano H; Hino M; Miura K; Tatsumi N; Iwao H
Br J Pharmacol; 2002 Aug; 136(7):975-84. PubMed ID: 12145097
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
Wong CK; Tsang CM; Ip WK; Lam CW
Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinases mediate interleukin-1beta-induced receptor activator of nuclear factor-kappaB ligand expression in human periodontal ligament cells.
Oikawa A; Kobayashi M; Okamatsu Y; Shinki T; Kamijo R; Yamamoto M; Hasegawa K
J Periodontal Res; 2007 Aug; 42(4):367-76. PubMed ID: 17559635
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels.
Kondo T; Kitazawa R; Yamaguchi A; Kitazawa S
J Cell Biochem; 2008 Jan; 103(1):335-45. PubMed ID: 17516544
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.
Vidal ON; Sjögren K; Eriksson BI; Ljunggren O; Ohlsson C
Biochem Biophys Res Commun; 1998 Jul; 248(3):696-700. PubMed ID: 9703989
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
18. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
Wong CK; Li PW; Lam CW
Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
[TBL] [Abstract][Full Text] [Related]
19. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice.
Ciallella JR; Saporito M; Lund S; Leist M; Hasseldam H; McGann N; Smith CS; Bozyczko-Coyne D; Flood DG
Eur J Pharmacol; 2005 May; 515(1-3):179-87. PubMed ID: 15904918
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.
Kjellerup RB; Kragballe K; Iversen L; Johansen C
Exp Dermatol; 2008 Jun; 17(6):498-504. PubMed ID: 18081851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]